Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation

Using gene expression analysis, we have identified STAT3 as a key transcription factor that is a central mediator in the pro-oncogenic effects of hepatic radiofrequency ablation.